Companies:

 

Articles:

 

Stock summary

Companies:

 

Cynata Therapeutics Limited (ASX: CYP)

 
Service provided by WebLinkIR

Company news

Cover Image for ASX biotech stocks benefiting from the COVID-19 story

ASX biotech stocks benefiting from the COVID-19 story

Cover Image for Cynata Therapeutics gets approval for clinical trial on COVID-19

Cynata Therapeutics gets approval for clinical trial on COVID-19

Cover Image for Cynata Therapeutics’ stem cells could potentially help treat severe COVID-19 symptoms

Cynata Therapeutics’ stem cells could potentially help treat severe COVID-19 symptoms

Cover Image for Cynata Therapeutics has positive pre-clinical results using Cymerus stem cell platform to treat sepsis

Cynata Therapeutics has positive pre-clinical results using Cymerus stem cell platform to treat sepsis